In a significant development for Core Scientific, Inc. (CORZ), Brian Dobson of Clear Street upgraded the stock to a “Buy” rating on October 28, 2025. This recommendation, coupled with a price target increase to $23—a considerable upside from the current trading price of $20.09—has prompted renewed interest among investors. As the digital asset and blockchain landscape continues to evolve, this rating signals potential growth opportunities for shareholders.
Recent Price Action
In recent trading sessions, Core Scientific’s stock has shown a robust performance against market conditions. Currently priced at $20.09, the stock witnessed a slight uptick of $0.22, translating to a change percentage of approximately 1.11%. The stock’s performance has been notably volatile, with a 52-week high of $224.03, reflecting extreme fluctuations typical of cryptocurrencies and technology stocks. Its 52-week low, meanwhile, sits at $1.33.
Notably, trading volume has surged in recent days, with approximately 22,143,796 shares exchanging hands, significantly above the average volume of 15,822,273. This elevated activity underscores heightened investor interest, which is further emphasized by a high beta of 6.60, indicating a strong propensity for bigger price swings relative to the market.
[chart type=’price’ value=’CORZ’]
Short- and Long-Term Performance
Core Scientific’s stock has experienced impressive growth trends across multiple timeframes. Over the past 30 days, the stock soared by 15.93%, while quarterly returns have reached a remarkable 53.83%. This contrasts with the broader market, providing shareholders with a significant sense of reassurance. Year-to-date, the stock has delivered a commendable performance of 48.59%.
Volatility metrics align with this growth; the weekly volatility stands at a striking 8.3%. This reinforces the notion that while returns have been strong, the price remains susceptible to sharp swings, compelling investors to maintain a close watch on market movements.
[chart type=’performance’ value=’CORZ’]
Earnings / Financials
The latest earnings data suggests a mixed picture for Core Scientific. For the fiscal period ending on August 8, 2025, the company reported an actual earnings per share (EPS) of -$0.04, surpassing analysts’ expectations of -$0.07. This surprise of 42.86% indicates a positive direction for the firm’s earnings potential, contrasting with the previous quarter’s report where the company recorded an EPS of -$0.10 against an estimate of -$0.12—showing a smaller, yet positive surprise of 16.67%.
Despite negative earnings, the company’s better-than-expected performance may act as a catalyst for improving investor perception, reflecting operational improvements and fiscal discipline that overcome initial underperformance.
[chart type=’income-bar-chart’ value=’CORZ’]
Analyst / Consensus View
Analyst consensus on Core Scientific remains optimistic, following the recent upgrades. Total ratings are comprised of nine analysts, with six recommending a “Buy” and three opting for a “Hold.” Importantly, there are no “Sell” ratings, indicating a generally favorable sentiment. The average price target among analysts is approximately $21.61, with a low target of $15 and a high target set at $26. This could point to a substantial upside potential from current levels, suggesting confidence in both the company’s strategy and the future growth of the market segment it operates within.
[chart type=’analyst-ratings’ value=’CORZ’]
Stock Grading or Fundamental View
Core Scientific holds a Stocks Telegraph Grade score of 50, placing it in a neutral position. This metric aggregates various financial and market analyses, reflecting adequate fundamentals but pointing to areas for improvement. Investors may interpret the score as indicative of a bench-marked performance in its industry, hinting at both challenges and opportunities ripe for exploitation.
[chart type=’st-cards’ value=’CORZ’]
Conclusion
For investors considering an entry into Core Scientific, this stock appears best suited for those with a tolerance for risk and a keen interest in long-term growth in the digital asset space. While volatility has been pronounced, the recent upgrade and improving financial profiles suggest a potential for recovery and value creation. However, prospective investors should remain vigilant of the inherent risks associated with the industry, which can be subject to rapid shifts in sentiment and market conditions. As Core Scientific continues to navigate this landscape, watching how the company capitalizes on the favorable analyst sentiment and market developments will be crucial.